Table 3 Insulin products found in the pharmacies
Characteristics | Number of products | |
|---|---|---|
Type of insulin | Human insulin | |
Short-acting | 14 (7.53%) | |
Intermediate-acting | 10 (5.38%) | |
Mixed | 66 (35.48%) | |
Analogue insulin | ||
Rapid-acting | 23 (12.37%) | |
Long-acting | 28 (15.05%) | |
Mixed | 45 (24.19%) | |
Supplier | Imported | |
Novo Nordisk A/S | 93 (50.00%) | |
Eli Lilly Italia S.p.A./ Lilly France | 41 (22.04%) | |
Sanofi-Aventis Deutschland GmbH | 12 (6.45%) | |
BIOTON S.A. | 5 (2.69%) | |
Locally produced | ||
Gan Lee Pharmaceutical co., Ltd. | 7 (3.76%) | |
Dongbao Pharmaceutical co., Ltd. | 14 (7.53%) | |
Lianbang Ppharmaceutical co., Ltd. | 14 (7.53%) | |
Presentation | Cartridge, containing 300 IU/3 ml | 155 (83.33%) |
Prefilled Pen, containing 300 IU/3 ml | 31 (16.67%) | |